Marie-Francoise Chesselet - Publications

Affiliations: 
University of California, Los Angeles, Los Angeles, CA 

204 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Hatami A, Zhu C, Relaño-Gines A, Elias C, Galstyan A, Jun M, Milne G, Cantor CR, Chesselet MF, Shchepinov MS. Deuterium-reinforced linoleic acid lowers lipid peroxidation and mitigates cognitive impairment in the Q140 knock in mouse model of Huntington's disease. The Febs Journal. PMID 29933522 DOI: 10.1111/febs.14590  0.4
2018 Subramaniam SR, Magen I, Bove N, Zhu C, Lemesre V, Dutta G, Elias CJ, Lester HA, Chesselet MF. Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type α-synuclein. Neurobiology of Disease. PMID 29859873 DOI: 10.1016/j.nbd.2018.05.018  0.4
2017 Reidling JC, Relaño-Ginés A, Holley SM, Ochaba J, Moore C, Fury B, Lau A, Tran AH, Yeung S, Salamati D, Zhu C, Hatami A, Cepeda C, Barry JA, Kamdjou T, ... ... Chesselet MF, et al. Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice. Stem Cell Reports. PMID 29233555 DOI: 10.1016/j.stemcr.2017.11.005  0.76
2017 Richter F, Subramaniam SR, Magen I, Lee P, Hayes J, Attar A, Zhu C, Franich NR, Bove N, De La Rosa K, Kwong J, Klärner FG, Schrader T, Chesselet MF, Bitan G. A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-Synuclein. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 28585223 DOI: 10.1007/s13311-017-0544-9  0.4
2016 Wrasidlo W, Tsigelny IF, Price DL, Dutta G, Rockenstein E, Schwarz TC, Ledolter K, Bonhaus D, Paulino A, Eleuteri S, Skjevik ÅA, Kouznetsova VL, Spencer B, Desplats P, Gonzalez-Ruelas T, ... ... Chesselet MF, et al. A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease. Brain : a Journal of Neurology. PMID 27679481 DOI: 10.1093/brain/aww238  0.4
2015 Eskow Jaunarajs KL, Bonsi P, Chesselet MF, Standaert DG, Pisani A. Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia. Progress in Neurobiology. 127: 91-107. PMID 25697043 DOI: 10.1016/j.pneurobio.2015.02.002  0.96
2015 Magen I, Torres ER, Dinh D, Chung A, Masliah E, Chesselet MF. Social Cognition Impairments in Mice Overexpressing Alpha-Synuclein Under the Thy1 Promoter, a Model of Pre-manifest Parkinson's Disease. Journal of Parkinson's Disease. PMID 25588356 DOI: 10.3233/JPD-140503  0.96
2015 Hatami A, Chesselet MF. Transgenic rodent models to study alpha-synuclein pathogenesis, with a focus on cognitive deficits. Current Topics in Behavioral Neurosciences. 22: 303-30. PMID 25218491 DOI: 10.1007/7854_2014_355  0.96
2014 Magen I, Ostritsky R, Richter F, Zhu C, Fleming SM, Lemesre V, Stewart AJ, Morimoto BH, Gozes I, Chesselet MF. Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein. Pharmacology Research & Perspectives. 2: e00065. PMID 25505609 DOI: 10.1002/prp2.65  0.52
2014 Richter F, Fleming SM, Watson M, Lemesre V, Pellegrino L, Ranes B, Zhu C, Mortazavi F, Mulligan CK, Sioshansi PC, Hean S, De La Rosa K, Khanna R, Flanagan J, Lockhart DJ, ... ... Chesselet MF, et al. A GCase chaperone improves motor function in a mouse model of synucleinopathy. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 11: 840-56. PMID 25037721 DOI: 10.1007/s13311-014-0294-x  0.96
2014 Subramaniam SR, Vergnes L, Franich NR, Reue K, Chesselet MF. Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein. Neurobiology of Disease. 70: 204-13. PMID 25016198 DOI: 10.1016/j.nbd.2014.06.017  0.96
2014 McDowell KA, Shin D, Roos KP, Chesselet MF. Sleep dysfunction and EEG alterations in mice overexpressing alpha-synuclein. Journal of Parkinson's Disease. 4: 531-9. PMID 24867919 DOI: 10.3233/JPD-140374  0.96
2014 Richter F, Gao F, Medvedeva V, Lee P, Bove N, Fleming SM, Michaud M, Lemesre V, Patassini S, De La Rosa K, Mulligan CK, Sioshansi PC, Zhu C, Coppola G, Bordet T, ... ... Chesselet MF, et al. Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons. Neurobiology of Disease. 69: 263-75. PMID 24844147 DOI: 10.1016/j.nbd.2014.05.012  0.96
2014 Grant LM, Richter F, Miller JE, White SA, Fox CM, Zhu C, Chesselet MF, Ciucci MR. Vocalization deficits in mice over-expressing alpha-synuclein, a model of pre-manifest Parkinson's disease. Behavioral Neuroscience. 128: 110-21. PMID 24773432 DOI: 10.1037/a0035965  0.96
2013 Fleming SM, Jordan MC, Mulligan CK, Masliah E, Holden JG, Millard RW, Chesselet MF, Roos KP. Impaired baroreflex function in mice overexpressing alpha-synuclein. Frontiers in Neurology. 4: 103. PMID 23888153 DOI: 10.3389/fneur.2013.00103  0.96
2013 Subramaniam SR, Chesselet MF. Mitochondrial dysfunction and oxidative stress in Parkinson's disease. Progress in Neurobiology. 106: 17-32. PMID 23643800 DOI: 10.1016/j.pneurobio.2013.04.004  0.96
2013 Lagière M, Navailles S, Mignon L, Roumegous A, Chesselet MF, De Deurwaerdère P. The enhanced oral response to the 5-HT2 agonist Ro 60-0175 in parkinsonian rats involves the entopeduncular nucleus: electrophysiological correlates. Experimental Brain Research. 230: 513-24. PMID 23535834 DOI: 10.1007/s00221-013-3478-4  0.96
2013 Watson MB, Nobuta H, Abad C, Lee SK, Bala N, Zhu C, Richter F, Chesselet MF, Waschek JA. PACAP deficiency sensitizes nigrostriatal dopaminergic neurons to paraquat-induced damage and modulates central and peripheral inflammatory activation in mice. Neuroscience. 240: 277-86. PMID 23500093 DOI: 10.1016/j.neuroscience.2013.03.002  0.96
2013 Navailles S, Lagière M, Roumegous A, Polito M, Boujema MB, Cador M, Dunlop J, Chesselet MF, Millan MJ, De Deurwaerdère P. Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson's disease. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 593-606. PMID 22717119 DOI: 10.1017/S1461145712000417  0.96
2013 Chesselet MF, Richter F, Gao F, Fleming SM, Michaud M, Zhu C, Coppola G, Bordet T, Pruss R. Mitochondria-Targeted Cholesterol Oximes Increase Dopamine-Related Gene Expression and Behavior in Mice Over-Expressing Alpha-Synuclein, a Model of Pre-Manifest Parkinson's Disease Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 128. DOI: 10.1016/B978-0-12-800044-1.00112-4  0.96
2012 Wang L, Magen I, Yuan PQ, Subramaniam SR, Richter F, Chesselet MF, Taché Y. Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 24: e425-36. PMID 22779732 DOI: 10.1111/j.1365-2982.2012.01974.x  0.96
2012 Watson MB, Richter F, Lee SK, Gabby L, Wu J, Masliah E, Effros RB, Chesselet MF. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein. Experimental Neurology. 237: 318-34. PMID 22750327 DOI: 10.1016/j.expneurol.2012.06.025  0.96
2012 Hickey MA, Zhu C, Medvedeva V, Lerner RP, Patassini S, Franich NR, Maiti P, Frautschy SA, Zeitlin S, Levine MS, Chesselet MF. Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease. Molecular Neurodegeneration. 7: 12. PMID 22475209 DOI: 10.1186/1750-1326-7-12  0.96
2012 Chesselet MF, Carmichael ST. Animal models of neurological disorders. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 9: 241-4. PMID 22460561 DOI: 10.1007/s13311-012-0118-9  0.96
2012 Magen I, Fleming SM, Zhu C, Garcia EC, Cardiff KM, Dinh D, De La Rosa K, Sanchez M, Torres ER, Masliah E, Jentsch JD, Chesselet MF. Cognitive deficits in a mouse model of pre-manifest Parkinson's disease. The European Journal of Neuroscience. 35: 870-82. PMID 22356593 DOI: 10.1111/j.1460-9568.2012.08012.x  0.96
2012 Chesselet MF, Richter F, Zhu C, Magen I, Watson MB, Subramaniam SR. A progressive mouse model of Parkinson's disease: the Thy1-aSyn ("Line 61") mice. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 9: 297-314. PMID 22350713 DOI: 10.1007/s13311-012-0104-2  0.96
2012 Lerner RP, Trejo Martinez Ldel C, Zhu C, Chesselet MF, Hickey MA. Striatal atrophy and dendritic alterations in a knock-in mouse model of Huntington's disease. Brain Research Bulletin. 87: 571-8. PMID 22326483 DOI: 10.1016/j.brainresbull.2012.01.012  0.96
2012 McDowell K, Chesselet MF. Animal models of the non-motor features of Parkinson's disease. Neurobiology of Disease. 46: 597-606. PMID 22236386 DOI: 10.1016/j.nbd.2011.12.040  0.96
2012 Hickey MA, Zhu C, Medvedeva V, Franich NR, Levine MS, Chesselet MF. Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease. Molecular and Cellular Neurosciences. 49: 149-57. PMID 22044764 DOI: 10.1016/j.mcn.2011.10.007  0.96
2012 Hickey MA, Franich NR, Medvedeva V, Chesselet MF. Mouse Models of Mental Illness and Neurological Disease: Huntington s Disease The Mouse Nervous System. 752-765. DOI: 10.1016/B978-0-12-369497-3.10032-9  0.96
2011 Magen I, Chesselet MF. Mouse models of cognitive deficits due to alpha-synuclein pathology. Journal of Parkinson's Disease. 1: 217-27. PMID 23939303 DOI: 10.3233/JPD-2011-11043  0.96
2011 Cabeza-Arvelaiz Y, Fleming SM, Richter F, Masliah E, Chesselet MF, Schiestl RH. Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons. Molecular Neurodegeneration. 6: 83. PMID 22165993 DOI: 10.1186/1750-1326-6-83  0.96
2011 Chesselet MF, Richter F. Modelling of Parkinson's disease in mice. The Lancet. Neurology. 10: 1108-18. PMID 22094131 DOI: 10.1016/S1474-4422(11)70227-7  0.96
2011 Hutson CB, Lazo CR, Mortazavi F, Giza CC, Hovda D, Chesselet MF. Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat. Journal of Neurotrauma. 28: 1783-801. PMID 21644813 DOI: 10.1089/neu.2010.1723  0.96
2011 Lam HA, Wu N, Cely I, Kelly RL, Hean S, Richter F, Magen I, Cepeda C, Ackerson LC, Walwyn W, Masliah E, Chesselet MF, Levine MS, Maidment NT. Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α-synuclein. Journal of Neuroscience Research. 89: 1091-102. PMID 21488084 DOI: 10.1002/jnr.22611  0.96
2011 Fleming SM, Mulligan CK, Richter F, Mortazavi F, Lemesre V, Frias C, Zhu C, Stewart A, Gozes I, Morimoto B, Chesselet MF. A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions. Molecular and Cellular Neurosciences. 46: 597-606. PMID 21193046 DOI: 10.1016/j.mcn.2010.12.011  0.96
2011 Hickey MA, Chesselet MF. Behavioral assessment of genetic mouse models of Huntington's disease Neuromethods. 62: 3-19. DOI: 10.1007/978-1-61779-301-1_1  0.96
2011 Fleming SM, Jentsch JD, Chesselet MF. Cognitive dysfunction in genetic mouse models of parkinsonism Neuromethods. 48: 485-492. DOI: 10.1007/978-1-60761-898-0_25  0.96
2010 Magen I, Chesselet MF. Genetic mouse models of Parkinson's disease The state of the art. Progress in Brain Research. 184: 53-87. PMID 20887870 DOI: 10.1016/S0079-6123(10)84004-X  0.96
2010 De Deurwaerdère P, Le Moine C, Chesselet MF. Selective blockade of serotonin 2C receptor enhances Fos expression specifically in the striatum and the subthalamic nucleus within the basal ganglia. Neuroscience Letters. 469: 251-5. PMID 20004702 DOI: 10.1016/j.neulet.2009.12.006  0.96
2010 Chesselet MF, Hickey MA, Zhu C, Levine MS. Huntington's Disease: Neurodegeneration Encyclopedia of Neuroscience. 39-44. DOI: 10.1016/B978-008045046-9.00511-8  0.96
2009 Steele AD, Zhou Z, Jackson WS, Zhu C, Auluck P, Moskowitz MA, Chesselet MF, Lindquist S. Context dependent neuroprotective properties of prion protein (PrP). Prion. 3: 240-9. PMID 19901559  0.96
2009 Hoang T, Choi DK, Nagai M, Wu DC, Nagata T, Prou D, Wilson GL, Vila M, Jackson-Lewis V, Dawson VL, Dawson TM, Chesselet MF, Przedborski S. Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson disease. Free Radical Biology & Medicine. 47: 1049-56. PMID 19616617 DOI: 10.1016/j.freeradbiomed.2009.07.013  0.96
2009 Richter F, Meurers BH, Zhu C, Medvedeva VP, Chesselet MF. Neurons express hemoglobin alpha- and beta-chains in rat and human brains. The Journal of Comparative Neurology. 515: 538-47. PMID 19479992 DOI: 10.1002/cne.22062  0.96
2009 Lu XH, Fleming SM, Meurers B, Ackerson LC, Mortazavi F, Lo V, Hernandez D, Sulzer D, Jackson GR, Maidment NT, Chesselet MF, Yang XW. Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 1962-76. PMID 19228951 DOI: 10.1523/JNEUROSCI.5351-08.2009  0.96
2009 Phan J, Hickey MA, Zhang P, Chesselet MF, Reue K. Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models. Human Molecular Genetics. 18: 1006-16. PMID 19124532 DOI: 10.1093/hmg/ddn428  0.96
2009 Meurers BH, Zhu C, Fernagut PO, Richter F, Hsia YC, Fleming SM, Oh M, Elashoff D, Dicarlo CD, Seaman RL, Chesselet MF. Low dose rotenone treatment causes selective transcriptional activation of cell death related pathways in dopaminergic neurons in vivo. Neurobiology of Disease. 33: 182-92. PMID 19013527 DOI: 10.1016/j.nbd.2008.10.001  0.96
2009 Chesselet MF, Ritz B. Transcriptional regulation of α-synuclein: Insights from blood? Future Neurology. 4: 145-147. DOI: 10.2217/14796708.4.2.145  0.96
2008 Chou AP, Maidment N, Klintenberg R, Casida JE, Li S, Fitzmaurice AG, Fernagut PO, Mortazavi F, Chesselet MF, Bronstein JM. Ziram causes dopaminergic cell damage by inhibiting E1 ligase of the proteasome. The Journal of Biological Chemistry. 283: 34696-703. PMID 18818210 DOI: 10.1074/jbc.M802210200  0.96
2008 Hickey MA, Kosmalska A, Enayati J, Cohen R, Zeitlin S, Levine MS, Chesselet MF. Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice. Neuroscience. 157: 280-95. PMID 18805465 DOI: 10.1016/j.neuroscience.2008.08.041  0.96
2008 Fleming SM, Tetreault NA, Mulligan CK, Hutson CB, Masliah E, Chesselet MF. Olfactory deficits in mice overexpressing human wildtype alpha-synuclein. The European Journal of Neuroscience. 28: 247-56. PMID 18702696 DOI: 10.1111/j.1460-9568.2008.06346.x  0.96
2008 Chesselet MF, Fleming S, Mortazavi F, Meurers B. Strengths and limitations of genetic mouse models of Parkinson's disease. Parkinsonism & Related Disorders. 14: S84-7. PMID 18585084 DOI: 10.1016/j.parkreldis.2008.04.004  0.96
2008 Wang L, Fleming SM, Chesselet MF, Taché Y. Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein. Neuroreport. 19: 873-6. PMID 18463504 DOI: 10.1097/WNR.0b013e3282ffda5e  0.96
2008 Effros RB, Austad S, Blau H, Chesselet MF, Ingram D, Johnson TE, Kaeberlein M, Lundblad V, McCarter R, McElhaney J, Saag M. The biological sciences section program at the 60th Annual Meeting of the Gerontological Society of America. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 63: 331-7. PMID 18426956  0.96
2008 Meredith GE, Sonsalla PK, Chesselet MF. Animal models of Parkinson's disease progression. Acta Neuropathologica. 115: 385-98. PMID 18273623 DOI: 10.1007/s00401-008-0350-x  0.96
2008 Reliene R, Fleming SM, Chesselet MF, Schiestl RH. Effects of antioxidants on cancer prevention and neuromotor performance in Atm deficient mice. Food and Chemical Toxicology : An International Journal Published For the British Industrial Biological Research Association. 46: 1371-7. PMID 18037553 DOI: 10.1016/j.fct.2007.08.028  0.96
2008 Chesselet MF. In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson's disease? Experimental Neurology. 209: 22-7. PMID 17949715 DOI: 10.1016/j.expneurol.2007.08.006  0.96
2008 Chesselet MF, Fernagut PO. Environmental Explorations of Parkinson's Disease Using Rodent Genetic Models Parkinson's Disease. 285-294. DOI: 10.1016/B978-0-12-374028-1.00021-X  0.96
2008 Merchant KM, Chesselet MF, Hu SC, Fahn S. Animal models of parkinson's disease to aid drug discovery and development Animal and Translational Models For Cns Drug Discovery. 2: 159-205. DOI: 10.1016/B978-0-12-373861-5.00017-5  0.96
2007 Fernagut PO, Hutson CB, Fleming SM, Tetreaut NA, Salcedo J, Masliah E, Chesselet MF. Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression. Synapse (New York, N.Y.). 61: 991-1001. PMID 17879265 DOI: 10.1002/syn.20456  0.96
2007 Chesselet MF, Plotkin JL, Wu N, Levine MS. Development of striatal fast-spiking GABAergic interneurons. Progress in Brain Research. 160: 261-72. PMID 17499119 DOI: 10.1016/S0079-6123(06)60015-0  0.96
2007 Litvan I, Chesselet MF, Gasser T, Di Monte DA, Parker D, Hagg T, Hardy J, Jenner P, Myers RH, Price D, Hallett M, Langston WJ, Lang AE, Halliday G, Rocca W, et al. The etiopathogenesis of Parkinson disease and suggestions for future research. Part II. Journal of Neuropathology and Experimental Neurology. 66: 329-36. PMID 17483689 DOI: 10.1097/nen.0b013e318053716a  0.96
2007 Litvan I, Halliday G, Hallett M, Goetz CG, Rocca W, Duyckaerts C, Ben-Shlomo Y, Dickson DW, Lang AE, Chesselet MF, Langston WJ, Di Monte DA, Gasser T, Hagg T, Hardy J, et al. The etiopathogenesis of Parkinson disease and suggestions for future research. Part I. Journal of Neuropathology and Experimental Neurology. 66: 251-7. PMID 17413315 DOI: 10.1097/nen.0b013e3180415e42  0.96
2006 Fleming SM, Chesselet MF. Behavioral phenotypes and pharmacology in genetic mouse models of Parkinsonism. Behavioural Pharmacology. 17: 383-91. PMID 16940759 DOI: 10.1097/00008877-200609000-00004  0.96
2006 Fleming SM, Salcedo J, Hutson CB, Rockenstein E, Masliah E, Levine MS, Chesselet MF. Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein. Neuroscience. 142: 1245-53. PMID 16934409 DOI: 10.1016/j.neuroscience.2006.07.005  0.96
2006 Dewing P, Chiang CW, Sinchak K, Sim H, Fernagut PO, Kelly S, Chesselet MF, Micevych PE, Albrecht KH, Harley VR, Vilain E. Direct regulation of adult brain function by the male-specific factor SRY. Current Biology : Cb. 16: 415-20. PMID 16488877 DOI: 10.1016/j.cub.2006.01.017  0.96
2006 Riban V, Chesselet MF. Region-specific sprouting of crossed corticofugal fibers after unilateral cortical lesions in adult mice. Experimental Neurology. 197: 451-7. PMID 16321385 DOI: 10.1016/j.expneurol.2005.10.026  0.96
2005 Fleming SM, Fernagut PO, Chesselet MF. Genetic mouse models of parkinsonism: strengths and limitations. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 2: 495-503. PMID 16389313 DOI: 10.1602/neurorx.2.3.495  0.96
2005 Chesselet MF. Animal models of neurological disorders. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 2: 395. PMID 16389303 DOI: 10.1602/neurorx.2.3.395  0.96
2005 Plotkin JL, Wu N, Chesselet MF, Levine MS. Functional and molecular development of striatal fast-spiking GABAergic interneurons and their cortical inputs. The European Journal of Neuroscience. 22: 1097-108. PMID 16176351 DOI: 10.1111/j.1460-9568.2005.04303.x  0.96
2005 Hickey MA, Gallant K, Gross GG, Levine MS, Chesselet MF. Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing. Neurobiology of Disease. 20: 1-11. PMID 16137562 DOI: 10.1016/j.nbd.2005.01.024  0.96
2005 Mignon L, Vourc'h P, Romero-Ramos M, Osztermann P, Young HE, Lucas PA, Chesselet MF. Transplantation of multipotent cells extracted from adult skeletal muscles into the subventricular zone of adult rats. The Journal of Comparative Neurology. 491: 96-108. PMID 16127692 DOI: 10.1002/cne.20685  0.96
2005 Gotts JE, Chesselet MF. Mechanisms of subventricular zone expansion after focal cortical ischemic injury. The Journal of Comparative Neurology. 488: 201-14. PMID 15924343 DOI: 10.1002/cne.20609  0.96
2005 Gotts JE, Chesselet MF. Vascular changes in the subventricular zone after distal cortical lesions. Experimental Neurology. 194: 139-50. PMID 15899251 DOI: 10.1016/j.expneurol.2005.02.001  0.96
2005 Vourc'h P, Lacar B, Mignon L, Lucas PA, Young HE, Chesselet MF. Effect of neurturin on multipotent cells isolated from the adult skeletal muscle. Biochemical and Biophysical Research Communications. 332: 215-23. PMID 15896320 DOI: 10.1016/j.bbrc.2005.04.104  0.96
2005 Mehta A, Chesselet MF. Effect of GABA(A) receptor stimulation in the subthalamic nucleus on motor deficits induced by nigrostriatal lesions in the rat. Experimental Neurology. 193: 110-7. PMID 15817269 DOI: 10.1016/j.expneurol.2005.01.001  0.96
2005 Gotts JE, Chesselet MF. Migration and fate of newly born cells after focal cortical ischemia in adult rats. Journal of Neuroscience Research. 80: 160-71. PMID 15751027 DOI: 10.1002/jnr.20434  0.96
2005 Mehta A, Menalled L, Chesselet MF. Behavioral responses to injections of muscimol into the subthalamic nucleus: temporal changes after nigrostriatal lesions. Neuroscience. 131: 769-78. PMID 15730880 DOI: 10.1016/j.neuroscience.2004.11.036  0.96
2005 Hwang DY, Fleming SM, Ardayfio P, Moran-Gates T, Kim H, Tarazi FI, Chesselet MF, Kim KS. 3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 2132-7. PMID 15728853 DOI: 10.1523/JNEUROSCI.3718-04.2005  0.96
2005 Chesselet MF, Fernagut PO, Fleming S. Parkinson's disease models: From toxins to genes Drug Discovery Today: Disease Models. 2: 299-303. DOI: 10.1016/j.ddmod.2005.11.008  0.96
2005 Fleming SM, Chesselet MF. Phenotypical characterization of genetic mouse models of parkinson disease Movement Disorders. 183-192. DOI: 10.1016/B978-012088382-0/50015-3  0.96
2004 Fleming SM, Salcedo J, Fernagut PO, Rockenstein E, Masliah E, Levine MS, Chesselet MF. Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 9434-40. PMID 15496679 DOI: 10.1523/JNEUROSCI.3080-04.2004  0.96
2004 Fernagut PO, Chesselet MF. Alpha-synuclein and transgenic mouse models. Neurobiology of Disease. 17: 123-30. PMID 15474350 DOI: 10.1016/j.nbd.2004.07.001  0.96
2004 Levine MS, Cepeda C, Hickey MA, Fleming SM, Chesselet MF. Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect. Trends in Neurosciences. 27: 691-7. PMID 15474170 DOI: 10.1016/j.tins.2004.08.008  0.96
2004 Zhu C, Vourc'h P, Fernagut PO, Fleming SM, Lacan S, Dicarlo CD, Seaman RL, Chesselet MF. Variable effects of chronic subcutaneous administration of rotenone on striatal histology. The Journal of Comparative Neurology. 478: 418-26. PMID 15384065 DOI: 10.1002/cne.20305  0.96
2004 Fleming SM, Zhu C, Fernagut PO, Mehta A, DiCarlo CD, Seaman RL, Chesselet MF. Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone. Experimental Neurology. 187: 418-29. PMID 15144868 DOI: 10.1016/j.expneurol.2004.01.023  0.96
2004 Vourc'h P, Romero-Ramos M, Chivatakarn O, Young HE, Lucas PA, El-Kalay M, Chesselet MF. Isolation and characterization of cells with neurogenic potential from adult skeletal muscle. Biochemical and Biophysical Research Communications. 317: 893-901. PMID 15081424 DOI: 10.1016/j.bbrc.2004.03.121  0.96
2004 Mir HM, Tatsukawa KJ, Carmichael ST, Chesselet MF, Kornblum HI. Metabolic correlates of lesion-specific plasticity: an in vivo imaging study. Brain Research. 1002: 28-34. PMID 14988030 DOI: 10.1016/j.brainres.2003.12.006  0.96
2004 Young HE, Duplaa C, Romero-Ramos M, Chesselet MF, Vourc'h P, Yost MJ, Ericson K, Terracio L, Asahara T, Masuda H, Tamura-Ninomiya S, Detmer K, Bray RA, Steele TA, Hixson D, et al. Adult reserve stem cells and their potential for tissue engineering. Cell Biochemistry and Biophysics. 40: 1-80. PMID 14983110 DOI: 10.1385/CBB:40:1:1  0.96
2004 Oberlin SR, Konakova M, Pulst S, Chesselet MF. Development and anatomic localization of torsinA. Advances in Neurology. 94: 61-5. PMID 14509655  0.96
2003 Hickey MA, Chesselet MF. The use of transgenic and knock-in mice to study Huntington's disease. Cytogenetic and Genome Research. 100: 276-86. PMID 14526189 DOI: 10.1159/000072863  0.96
2003 Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, Bhatnagar A, Meloni EG, Wu N, Ackerson LC, Klapstein GJ, Gajendiran M, Roth BL, Chesselet MF, Maidment NT, Levine MS, et al. Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. The Journal of Biological Chemistry. 278: 43628-35. PMID 12930822 DOI: 10.1074/jbc.M308947200  0.96
2003 Menalled LB, Sison JD, Dragatsis I, Zeitlin S, Chesselet MF. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats. The Journal of Comparative Neurology. 465: 11-26. PMID 12926013 DOI: 10.1002/cne.10776  0.96
2003 Chesselet MF. Dopamine and Parkinson's disease: is the killer in the house? Molecular Psychiatry. 8: 369-70. PMID 12740592 DOI: 10.1038/sj.mp.4001289  0.96
2003 Hickey MA, Chesselet MF. Apoptosis in Huntington's disease. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 27: 255-65. PMID 12657365 DOI: 10.1016/S0278-5846(03)00021-6  0.96
2002 Menalled LB, Sison JD, Wu Y, Olivieri M, Li XJ, Li H, Zeitlin S, Chesselet MF. Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 8266-76. PMID 12223581  0.96
2002 Romero-Ramos M, Vourc'h P, Young HE, Lucas PA, Wu Y, Chivatakarn O, Zaman R, Dunkelman N, el-Kalay MA, Chesselet MF. Neuronal differentiation of stem cells isolated from adult muscle. Journal of Neuroscience Research. 69: 894-907. PMID 12205682 DOI: 10.1002/jnr.10374  0.96
2002 Carmichael ST, Chesselet MF. Synchronous neuronal activity is a signal for axonal sprouting after cortical lesions in the adult. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 6062-70. PMID 12122067  0.96
2002 Toneff T, Mende-Mueller L, Wu Y, Hwang SR, Bundey R, Thompson LM, Chesselet MF, Hook V. Comparison of huntingtin proteolytic fragments in human lymphoblast cell lines and human brain. Journal of Neurochemistry. 82: 84-92. PMID 12091468 DOI: 10.1046/j.1471-4159.2002.00940.x  0.96
2002 Menalled LB, Chesselet MF. Mouse models of Huntington's disease. Trends in Pharmacological Sciences. 23: 32-9. PMID 11804649 DOI: 10.1016/S0165-6147(00)01884-8  0.96
2002 Chesselet MF, Welsh G. Neurobiologie et psychanalyse : Deux études à quatre mains sur la schizophrénie et sur la prescription de psychotropes dans un trouble obsessionnel Revue Francaise De Psychanalyse. 66: 385-408. DOI: 10.3917/rfp.662.0385  0.96
2001 Chesselet MF, MacKenzie L, Hoang T. Detection of DNA damage in tissue sections by in situ nick translation. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 1.9. PMID 18428455 DOI: 10.1002/0471142301.ns0109s16  0.96
2001 Klapstein GJ, Fisher RS, Zanjani H, Cepeda C, Jokel ES, Chesselet MF, Levine MS. Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. Journal of Neurophysiology. 86: 2667-77. PMID 11731527  0.96
2001 Uryu K, MacKenzie L, Chesselet MF. Ultrastructural evidence for differential axonal sprouting in the striatum after thermocoagulatory and aspiration lesions of the cerebral cortex in adult rats. Neuroscience. 105: 307-16. PMID 11672598 DOI: 10.1016/S0306-4522(01)00203-2  0.96
2001 Mehta A, Bot G, Reisine T, Chesselet MF. Endomorphin-1: induction of motor behavior and lack of receptor desensitization. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 4436-42. PMID 11404430  0.96
2001 Mehta A, Eberle-Wang K, Chesselet MF. Increased m-CPP-induced oral dyskinesia after lesion of serotonergic neurons. Pharmacology, Biochemistry, and Behavior. 68: 347-53. PMID 11267640 DOI: 10.1016/S0091-3057(00)00476-7  0.96
2001 Mende-Mueller LM, Toneff T, Hwang SR, Chesselet MF, Hook VY. Tissue-specific proteolysis of Huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 1830-7. PMID 11245667  0.96
2000 Mehta A, Thermos K, Chesselet MF. Increased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions. Synapse (New York, N.Y.). 37: 298-307. PMID 10891867 DOI: 10.1002/1098-2396(20000915)37:4<298::AID-SYN7>3.0.CO;2-A  0.96
2000 De Deurwaèrdere P, Chesselet MF. Nigrostriatal lesions alter oral dyskinesia and c-Fos expression induced by the serotonin agonist 1-(m-chlorophenyl)piperazine in adult rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 5170-8. PMID 10864974  0.96
2000 Menalled L, Zanjani H, MacKenzie L, Koppel A, Carpenter E, Zeitlin S, Chesselet MF. Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease. Experimental Neurology. 162: 328-42. PMID 10739639 DOI: 10.1006/exnr.1999.7327  0.96
2000 Chesselet MF. A structural defect in schizophrenia? Neuroreport. 11: F17.  0.96
1999 Levine MS, Klapstein GJ, Koppel A, Gruen E, Cepeda C, Vargas ME, Jokel ES, Carpenter EM, Zanjani H, Hurst RS, Efstratiadis A, Zeitlin S, Chesselet MF. Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease. Journal of Neuroscience Research. 58: 515-32. PMID 10533044 DOI: 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F  0.96
1999 Bordelon YM, Chesselet MF. Early effects of intrastriatal injections of quinolinic acid on microtubule-associated protein-2 and neuropeptides in rat basal ganglia. Neuroscience. 93: 843-53. PMID 10473250 DOI: 10.1016/S0306-4522(99)00239-0  0.96
1999 Bordelon YM, Mackenzie L, Chesselet MF. Morphology and compartmental location of cells exhibiting DNA damage after quinolinic acid injections into rat striatum. The Journal of Comparative Neurology. 412: 38-50. PMID 10440708 DOI: 10.1002/(SICI)1096-9861(19990913)412:1<38::AID-CNE3>3.0.CO;2-6  0.96
1999 Butler AK, Uryu K, Rougon G, Chesselet MF. N-methyl-D-aspartate receptor blockade affects polysialylated neural cell adhesion molecule expression and synaptic density during striatal development. Neuroscience. 89: 1169-81. PMID 10362305 DOI: 10.1016/S0306-4522(98)00358-3  0.96
1999 Uryu K, Butler AK, Chesselet MF. Synaptogenesis and ultrastructural localization of the polysialylated neural cell adhesion molecule in the developing striatum. The Journal of Comparative Neurology. 405: 216-32. PMID 10023811 DOI: 10.1002/(SICI)1096-9861(19990308)405:2<216::AID-CNE6>3.0.CO;2-6  0.96
1998 Napieralski JA, Banks RJ, Chesselet MF. Motor and somatosensory deficits following uni- and bilateral lesions of the cortex induced by aspiration or thermocoagulation in the adult rat. Experimental Neurology. 154: 80-8. PMID 9875270 DOI: 10.1006/exnr.1998.6893  0.96
1998 McLaughlin BA, Nelson D, Silver IA, Erecinska M, Chesselet MF. Methylmalonate toxicity in primary neuronal cultures. Neuroscience. 86: 279-90. PMID 9692761 DOI: 10.1016/S0306-4522(97)00594-0  0.96
1998 Butler AK, Uryu K, Chesselet MF. A role for N-methyl-D-aspartate receptors in the regulation of synaptogenesis and expression of the polysialylated form of the neural cell adhesion molecule in the developing striatum. Developmental Neuroscience. 20: 253-62. PMID 9691199 DOI: 10.1159/000017319  0.96
1998 McLaughlin BA, Nelson D, EreciÅ„ska M, Chesselet MF. Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor. Journal of Neurochemistry. 70: 2406-15. PMID 9603205  0.96
1998 Naudon L, Delfs JM, Clavel N, Lorden JF, Chesselet MF. Differential expression of glutamate decarboxylase messenger RNA in cerebellar Purkinje cells and deep cerebellar nuclei of the genetically dystonic rat. Neuroscience. 82: 1087-94. PMID 9466432 DOI: 10.1016/S0306-4522(97)00334-5  0.96
1998 Bordelon YM, Chesselet MF, EreciÅ„ska M, Silver IA. Effects of intrastriatal injection of quinolinic acid on electrical activity and extracellular ion concentrations in rat striatum in vivo. Neuroscience. 83: 459-69. PMID 9460754 DOI: 10.1016/S0306-4522(97)00421-1  0.96
1998 Chesselet MF, Delfs JM, Mackenzie L. Dopamine control of gene expression in basal ganglia nuclei: striatal and nonstriatal mechanisms. Advances in Pharmacology (San Diego, Calif.). 42: 674-7. PMID 9327989 DOI: 10.1016/S1054-3589(08)60838-8  0.96
1997 Butler AK, Uryu K, Morehouse V, Rougon G, Chesselet MF. Regulation of the polysialylated form of the neural cell adhesion molecule in the developing striatum: effects of cortical lesions. The Journal of Comparative Neurology. 389: 289-308. PMID 9416923 DOI: 10.1002/(SICI)1096-9861(19971215)389:2<289::AID-CNE8>3.0.CO;2-Y  0.96
1997 Bordelon YM, Chesselet MF, Nelson D, Welsh F, EreciÅ„ska M. Energetic dysfunction in quinolinic acid-lesioned rat striatum. Journal of Neurochemistry. 69: 1629-39. PMID 9326292  0.96
1997 Lee S, Williamson J, Lothman EW, Szele FG, Chesselet MF, Von Hagen S, Sapolsky RM, Mattson MP, Christakos S. Early induction of mRNA for calbindin-D28k and BDNF but not NT-3 in rat hippocampus after kainic acid treatment. Brain Research. Molecular Brain Research. 47: 183-94. PMID 9221916 DOI: 10.1016/S0169-328X(97)00043-0  0.96
1997 Eberle-Wang K, Mikeladze Z, Uryu K, Chesselet MF. Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats. The Journal of Comparative Neurology. 384: 233-47. PMID 9215720 DOI: 10.1002/(SICI)1096-9861(19970728)384:2<233::AID-CNE5>3.0.CO;2-2  0.96
1997 Feger J, Chesselet MF, Delfs JM. Updating the functional model of the basal ganglia Trends in Neurosciences. 20: 152-153. PMID 9106354 DOI: 10.1016/S0166-2236(96)01016-8  0.96
1996 Delfs JM, Ciaramitaro VM, Soghomonian JJ, Chesselet MF. Unilateral nigrostriatal lesions induce a bilateral increase in glutamate decarboxylase messenger RNA in the reticular thalamic nucleus. Neuroscience. 71: 383-95. PMID 9053794 DOI: 10.1016/0306-4522(95)00470-X  0.96
1996 Napieralski JA, Butler AK, Chesselet MF. Anatomical and functional evidence for lesion-specific sprouting of corticostriatal input in the adult rat. The Journal of Comparative Neurology. 373: 484-97. PMID 8889940 DOI: 10.1002/(SICI)1096-9861(19960930)373:4<484::AID-CNE2>3.0.CO;2-Y  0.96
1996 Chesselet MF, Delfs JM. Basal ganglia and movement disorders: an update. Trends in Neurosciences. 19: 417-22. PMID 8888518 DOI: 10.1016/S0166-2236(96)10052-7  0.96
1996 Eberle-Wang K, Lucki I, Chesselet MF. A role for the subthalamic nucleus in 5-HT2C-induced oral dyskinesia. Neuroscience. 72: 117-28. PMID 8730711 DOI: 10.1016/0306-4522(95)00548-X  0.96
1996 Szele FG, Chesselet MF. Cortical lesions induce an increase in cell number and PSA-NCAM expression in the subventricular zone of adult rats. The Journal of Comparative Neurology. 368: 439-54. PMID 8725350 DOI: 10.1002/(SICI)1096-9861(19960506)368:3<439::AID-CNE9>3.0.CO;2-6  0.96
1996 Ghasemzadeh MB, Sharma S, Surmeier DJ, Eberwine JH, Chesselet MF. Multiplicity of glutamate receptor subunits in single striatal neurons: an RNA amplification study. Molecular Pharmacology. 49: 852-9. PMID 8622635  0.96
1996 Eberle-Wang K, Mehta A, Banks RJA, Chesselet MF. Regulation of 5-HT2C receptors in the subthalamic nucleus following 5,7, DHT lesion in rats Faseb Journal. 10: A714.  0.96
1995 Szele FG, Alexander C, Chesselet MF. Expression of molecules associated with neuronal plasticity in the striatum after aspiration and thermocoagulatory lesions of the cerebral cortex in adult rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 4429-48. PMID 7790918  0.6
1995 Delfs JM, Anegawa NJ, Chesselet MF. Glutamate decarboxylase messenger RNA in rat pallidum: comparison of the effects of haloperidol, clozapine and combined haloperidol-scopolamine treatments. Neuroscience. 66: 67-80. PMID 7637876 DOI: 10.1016/0306-4522(94)00572-M  0.96
1995 Chesselet MF, Soghomonian JJ, Salin P. Anatomical localization and regulation of somatostatin gene expression in the basal ganglia and its clinical implications. Ciba Foundation Symposium. 190: 51-9; discussion 59-. PMID 7587652  0.96
1995 Delfs JM, Ellison GD, Mercugliano M, Chesselet MF. Expression of glutamic acid decarboxylase mRNA in striatum and pallidum in an animal model of tardive dyskinesia. Experimental Neurology. 133: 175-88. PMID 7544289 DOI: 10.1006/exnr.1995.1020  0.96
1995 Delfs JM, Ciaramitaro VM, Parry TJ, Chesselet MF. Subthalamic nucleus lesions: widespread effects on changes in gene expression induced by nigrostriatal dopamine depletion in rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 15: 6562-75. PMID 7472418  0.96
1994 Delfs JM, Kong H, Mestek A, Chen Y, Yu L, Reisine T, Chesselet MF. Expression of mu opioid receptor mRNA in rat brain: an in situ hybridization study at the single cell level. The Journal of Comparative Neurology. 345: 46-68. PMID 8089277 DOI: 10.1002/cne.903450104  0.96
1994 Szele FG, Dowling JJ, Gonzales C, Theveniau M, Rougon G, Chesselet MF. Pattern of expression of highly polysialylated neural cell adhesion molecule in the developing and adult rat striatum. Neuroscience. 60: 133-44. PMID 8052407 DOI: 10.1016/0306-4522(94)90209-7  0.96
1994 Delfs JM, Yu L, Ellison GD, Reisine T, Chesselet MF. Regulation of mu-opioid receptor mRNA in rat globus pallidus: effects of enkephalin increases induced by short- and long-term haloperidol administration. Journal of Neurochemistry. 63: 777-80. PMID 8035203  0.96
1994 Parry TJ, Eberle-Wang K, Lucki I, Chesselet MF. Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats. Experimental Neurology. 128: 181-90. PMID 7915675 DOI: 10.1006/exnr.1994.1126  0.96
1994 Lenz S, Perney TM, Qin Y, Robbins E, Chesselet MF. GABA-ergic interneurons of the striatum express the Shaw-like potassium channel Kv3.1. Synapse (New York, N.Y.). 18: 55-66. PMID 7825124 DOI: 10.1002/syn.890180108  0.96
1994 Huang JC, Chesselet MF, Aguirre GD. Decreased opsin mRNA and immunoreactivity in progressive rod-cone degeneration (prcd): cytochemical studies of early disease and degeneration. Experimental Eye Research. 58: 17-30. PMID 7512509 DOI: 10.1006/exer.1994.1191  0.96
1994 Delfs J, Yu L, Reisine T, Chesselet MF. The distribution and regulation of mu opioid receptor mRNA in rat basal ganglia Regulatory Peptides. 54: 79-80. DOI: 10.1016/0167-0115(94)90398-0  0.96
1993 Salin P, Chesselet MF. Expression of GAD (M(r) 67,000) and its messenger RNA in basal ganglia and cerebral cortex after ischemic cortical lesions in rats. Experimental Neurology. 119: 291-301. PMID 8432368 DOI: 10.1006/exnr.1993.1033  0.96
1993 Nothias F, Salin P, Peschanski M, Chesselet MF. Glutamic acid decarboxylase gene expression in thalamic reticular neurons transplanted as a cell suspension in the adult thalamus. Brain Research. Molecular Brain Research. 20: 245-53. PMID 8302162 DOI: 10.1016/0169-328X(93)90047-S  0.96
1993 Chesselet MF, Mercugliano M, Soghomonian JJ, Salin P, Qin Y, Gonzales C. Regulation of glutamic acid decarboxylase gene expression in efferent neurons of the basal ganglia. Progress in Brain Research. 99: 143-54. PMID 8108545  0.96
1992 Mercugliano M, Chesselet MF. Clozapine decreases enkephalin mRNA in rat striatum. Neuroscience Letters. 136: 10-4. PMID 1635659 DOI: 10.1016/0304-3940(92)90635-K  0.96
1992 Soghomonian JJ, Chesselet MF. Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat. Synapse (New York, N.Y.). 11: 124-33. PMID 1626311 DOI: 10.1002/syn.890110205  0.96
1992 Mercugliano M, Saller CF, Salama AI, U'Prichard DC, Chesselet MF. Clozapine and haloperidol have differential effects on glutamic acid decarboxylase mRNA in the pallidal nuclei of the rat. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 6: 179-87. PMID 1599608  0.96
1992 Mercugliano M, Soghomonian JJ, Qin Y, Nguyen HQ, Feldblum S, Erlander MG, Tobin AJ, Chesselet MF. Comparative distribution of messenger RNAs encoding glutamic acid decarboxylases (Mr 65,000 and Mr 67,000) in the basal ganglia of the rat. The Journal of Comparative Neurology. 318: 245-54. PMID 1583162 DOI: 10.1002/cne.903180302  0.96
1992 Gonzales C, Lin RC, Chesselet MF. Relative sparing of GABAergic interneurons in the striatum of gerbils with ischemia-induced lesions. Neuroscience Letters. 135: 53-8. PMID 1542438 DOI: 10.1016/0304-3940(92)90134-S  0.96
1992 Soghomonian JJ, Gonzales C, Chesselet MF. Messenger RNAs encoding glutamate-decarboxylases are differentially affected by nigrostriatal lesions in subpopulations of striatal neurons. Brain Research. 576: 68-79. PMID 1515913 DOI: 10.1016/0006-8993(92)90610-L  0.96
1992 Salin P, Chesselet MF. Paradoxical increase in striatal neuropeptide gene expression following ischemic lesions of the cerebral cortex. Proceedings of the National Academy of Sciences of the United States of America. 89: 9954-8. PMID 1409726 DOI: 10.1073/pnas.89.20.9954  0.96
1992 Weiss-Wunder LT, Chesselet MF. Acute and repeated administration of fluphenazine-N-mustard alters levels of tyrosine hydroxylase mRNA in subsets of mesencephalic dopaminergic neurons. Neuroscience. 49: 297-305. PMID 1359452 DOI: 10.1016/0306-4522(92)90097-L  0.96
1992 Qin Y, Soghomonian JJ, Chesselet MF. Effects of quinolinic acid on messenger RNAs encoding somatostatin and glutamic acid decarboxylases in the striatum of adult rats. Experimental Neurology. 115: 200-11. PMID 1346522 DOI: 10.1016/0014-4886(92)90054-T  0.96
1991 Szele FG, Artymyshyn R, Molinoff PB, Chesselet MF. Heterogeneous distribution of dopamine D2 receptor mRNA in the rat striatum: a quantitative analysis with in situ hybridization histochemistry. The Anatomical Record. 231: 548-58. PMID 1838906 DOI: 10.1002/ar.1092310416  0.96
1991 Albin RL, Qin Y, Young AB, Penney JB, Chesselet MF. Preproenkephalin messenger RNA-containing neurons in striatum of patients with symptomatic and presymptomatic Huntington's disease: an in situ hybridization study. Annals of Neurology. 30: 542-9. PMID 1838677 DOI: 10.1002/ana.410300406  0.96
1991 Gonzales C, Kaufman DL, Tobin AJ, Chesselet MF. Distribution of glutamic acid decarboxylase (Mr 67,000) in the basal ganglia of the rat: an immunohistochemical study with a selective cDNA-generated polyclonal antibody. Journal of Neurocytology. 20: 953-61. PMID 1783943 DOI: 10.1007/BF01187913  0.96
1991 Martin JL, Chesselet MF, Raynor K, Gonzales C, Reisine T. Differential distribution of somatostatin receptor subtypes in rat brain revealed by newly developed somatostatin analogs. Neuroscience. 41: 581-93. PMID 1678504 DOI: 10.1016/0306-4522(91)90351-N  0.96
1991 Soghomonian JJ, Chesselet MF. Lesions of the dopaminergic nigrostriatal pathway alter preprosomatostatin messenger RNA levels in the striatum, the entopeduncular nucleus and the lateral hypothalamus of the rat. Neuroscience. 42: 49-59. PMID 1677745 DOI: 10.1016/0306-4522(91)90149-I  0.96
1991 Chesselet MF, Gonzales C, Levitt P. Heterogeneous distribution of the limbic system-associated membrane protein in the caudate nucleus and substantia nigra of the cat. Neuroscience. 40: 725-33. PMID 1676494 DOI: 10.1016/0306-4522(91)90008-C  0.96
1991 Weiss-Wunder LT, Chesselet MF. Subpopulations of mesencephalic dopaminergic neurons express different levels of tyrosine hydroxylase messenger RNA. The Journal of Comparative Neurology. 303: 478-88. PMID 1672536 DOI: 10.1002/cne.903030312  0.96
1990 Gonzales C, Chesselet MF. Amygdalonigral pathway: an anterograde study in the rat with Phaseolus vulgaris leucoagglutinin (PHA-L). The Journal of Comparative Neurology. 297: 182-200. PMID 2370319 DOI: 10.1002/cne.902970203  0.96
1990 Litwak J, Mercugliano M, Chesselet MF, Oltmans GA. Increased glutamic acid decarboxylase (GAD) mRNA and GAD activity in cerebellar Purkinje cells following lesion-induced increases in cell firing. Neuroscience Letters. 116: 179-83. PMID 2259446 DOI: 10.1016/0304-3940(90)90406-Y  0.96
1990 Chesselet MF. Presynaptic regulation of dopamine release. Implications for the functional organization of the basal ganglia. Annals of the New York Academy of Sciences. 604: 17-22. PMID 2171393 DOI: 10.1111/j.1749-6632.1990.tb31979.x  0.96
1990 Henken DB, Battisti WP, Chesselet MF, Murray M, Tessler A. Expression of beta-preprotachykinin mRNA and tachykinins in rat dorsal root ganglion cells following peripheral or central axotomy. Neuroscience. 39: 733-42. PMID 2097525 DOI: 10.1016/0306-4522(90)90257-5  0.96
1990 Rougon G, Nédélec J, Malapert P, Goridis C, Chesselet MF. Post-translation modifications of neural cell surface molecules. Acta Histochemica. Supplementband. 38: 51-7. PMID 2080249  0.96
1990 Weiss-Wunder LT, Chesselet MF. Heterogeneous distribution of cytochrome oxidase activity in the rat substantia nigra: correlation with tyrosine hydroxylase and dynorphin immunoreactivities. Brain Research. 529: 269-76. PMID 1980845 DOI: 10.1016/0006-8993(90)90837-2  0.96
1990 Chesselet MF, Gonzales C, Lin CS, Polsky K, Jin BK. Ischemic damage in the striatum of adult gerbils: relative sparing of somatostatinergic and cholinergic interneurons contrasts with loss of efferent neurons. Experimental Neurology. 110: 209-18. PMID 1977609 DOI: 10.1016/0014-4886(90)90032-N  0.96
1990 Salin P, Mercugliano M, Chesselet MF. Differential effects of chronic treatment with haloperidol and clozapine on the level of preprosomatostatin mRNA in the striatum, nucleus accumbens, and frontal cortex of the rat. Cellular and Molecular Neurobiology. 10: 127-44. PMID 1970756 DOI: 10.1007/BF00733640  0.96
1990 Salin P, Chesselet MF. Effects of haloperidol and cortical lesions on the level of neuropeptide Y mRNA in the striatum of the rat: A study by in situ hybridization histochemistry Annals of the New York Academy of Sciences. 611: 459-462.  0.96
1989 Baldino F, Chesselet MF, Lewis ME. High-resolution in situ hybridization histochemistry. Methods in Enzymology. 168: 761-77. PMID 2725322  0.96
1989 Aaron LI, Chesselet MF. Heterogeneous distribution of polysialylated neuronal-cell adhesion molecule during post-natal development and in the adult: an immunohistochemical study in the rat brain. Neuroscience. 28: 701-10. PMID 2710339 DOI: 10.1016/0306-4522(89)90015-8  0.96
1989 Chesselet MF, Robbins E. Characterization of striatal neurons expressing high levels of glutamic acid decarboxylase messenger RNA. Brain Research. 492: 237-44. PMID 2568874 DOI: 10.1016/0006-8993(89)90906-2  0.96
1989 Weiss LT, Chesselet MF. Regional distribution and regulation of preprosomatostatin messenger RNA in the striatum, as revealed by in situ hybridization histochemistry. Brain Research. Molecular Brain Research. 5: 121-30. PMID 2566104 DOI: 10.1016/0169-328X(89)90003-X  0.96
1989 Chesselet MF, Robbins E. Regional differences in substance P-like immunoreactivity in the striatum correlate with levels of pre-protachykinin mRNA. Neuroscience Letters. 96: 47-53. PMID 2467230 DOI: 10.1016/0304-3940(89)90241-3  0.96
1988 Henken DB, Tessler A, Chesselet MF, Hudson A, Baldino F, Murray M. In situ hybridization of mRNA for beta-preprotachykinin and preprosomatostatin in adult rat dorsal root ganglia: comparison with immunocytochemical localization. Journal of Neurocytology. 17: 671-81. PMID 2905386 DOI: 10.1007/BF01260994  0.96
1988 Chesselet MF, Hook VY. Carboxypeptidase H-like immunoreactivity in the striatum of cats and monkeys. Regulatory Peptides. 20: 151-9. PMID 2452460 DOI: 10.1016/0167-0115(88)90048-1  0.96
1987 Chesselet MF, Affolter HU. Preprotachykinin messenger RNA detected by in situ hybridization in striatal neurons of the human brain. Brain Research. 410: 83-8. PMID 3580901 DOI: 10.1016/S0006-8993(87)80024-0  0.96
1987 Romo R, Gaudry-Talarmain YM, Chéramy A, Godeheu G, Leviel V, Chesselet MF, Glowinski J, Israël M. Different effects of electrical stimulation of the mesencephalic and pontine reticular formation on the release of dopamine and acetylcholine in the cat caudate nucleus. Neuroscience Letters. 78: 57-62. PMID 3039422 DOI: 10.1016/0304-3940(87)90561-1  0.96
1987 Chesselet MF, Weiss L, Wuenschell C, Tobin AJ, Affolter HU. Comparative distribution of mRNAs for glutamic acid decarboxylase, tyrosine hydroxylase, and tachykinins in the basal ganglia: an in situ hybridization study in the rodent brain. The Journal of Comparative Neurology. 262: 125-40. PMID 2887596 DOI: 10.1002/cne.902620110  0.96
1986 Chesselet MF, Graybiel AM. Striatal neurons expressing somatostatin-like immunoreactivity: evidence for a peptidergic interneuronal system in the cat. Neuroscience. 17: 547-71. PMID 2422590 DOI: 10.1016/0306-4522(86)90030-8  0.96
1986 Sandell JH, Graybiel AM, Chesselet MF. A new enzyme marker for striatal compartmentalization: NADPH diaphorase activity in the caudate nucleus and putamen of the cat. The Journal of Comparative Neurology. 243: 326-34. PMID 2419368 DOI: 10.1002/cne.902430304  0.96
1985 Chiueh CC, Johannessen JN, Chesselet MF, Markey SP. Neurotoxic mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its oxidative metabolites in the nigrostriatal system of C57BL6 mice Federation Proceedings. 44: No. 2815.  0.96
1984 Graybiel AM, Chesselet MF. Compartmental distribution of striatal cell bodies expressing [Met]enkephalin-like immunoreactivity. Proceedings of the National Academy of Sciences of the United States of America. 81: 7980-4. PMID 6440146  0.96
1984 Chesselet MF. Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis. Neuroscience. 12: 347-75. PMID 6146946 DOI: 10.1016/0306-4522(84)90058-7  0.96
1983 Chéramy A, Chesselet MF, Romo R, Leviel V, Glowinski J. Effects of unilateral electrical stimulation of various thalamic nuclei on the release of dopamine from dendrites and nerve terminals of neurons of the two nigrostriatal dopaminergic pathways. Neuroscience. 8: 767-80. PMID 6866262 DOI: 10.1016/0306-4522(83)90008-8  0.96
1983 Chesselet MF, Chéramy A, Reisine TD, Lubetzki C, Desban M, Glowinski J. Local and distal effects induced by unilateral striatal application of opiates in the absence or in the presence of naloxone on the release of dopamine in both caudate nuclei and substantiae nigrae of the cat. Brain Research. 258: 229-42. PMID 6824913 DOI: 10.1016/0006-8993(83)91146-0  0.96
1983 Chesselet MF, Cheramy A, Romo R, Desban M, Glowinski J. GABA in the thalamic motor nuclei modulates dopamine release from the two dopaminergic nigrostriatal pathways in the cat. Experimental Brain Research. 51: 275-82. PMID 6617796 DOI: 10.1007/BF00237203  0.96
1983 Chesselet MF, Graybiel AM. Met-enkephalin-like and dynorphin-like immunoreactivities of the basal ganglia of the cat. Life Sciences. 33: 37-40. PMID 6141495 DOI: 10.1016/0024-3205(83)90438-1  0.96
1983 Chesselet MF, Reisine TD. Somatostatin regulates dopamine release in rat striatal slices and cat caudate nuclei. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 3: 232-6. PMID 6130131  0.96
1982 Chesselet MF, Cheramy A, Reisine T, Lubetzki C, Glowinski J. Presynaptic regulation of striatal dopamine release: in vivo and in vitro studies. Journal De Physiologie. 78: 420-5. PMID 7182487  0.96
1982 Chesselet MF, Cheramy A, Reisine TD, Lubetzki C, Glowinski J, Fournie-Zaluski MC, Roques B. Effects of various opiates including specific delta and mu agonists on dopamine release from nigrostriatal dopaminergic neurons in vitro in the rat and in vivo in the cat. Life Sciences. 31: 2291-4. PMID 6298522 DOI: 10.1016/0024-3205(82)90140-0  0.96
1982 Reisine TD, Chesselet MF, Lubetzki C, Chéramy A, Glowinski J. A role for striatal beta-adrenergic receptors in the regulation of dopamine release. Brain Research. 241: 123-30. PMID 6286040 DOI: 10.1016/0006-8993(82)91235-5  0.96
1982 Lubetzki C, Chesselet MF, Glowinski J. Modulation of dopamine release in rat striatal slices by delta opiate agonists. The Journal of Pharmacology and Experimental Therapeutics. 222: 435-40. PMID 6284911  0.96
1982 Reisine T, Chesselet MF, Glowinski J. Striatal dopamine release in vitro: a beta-adrenoceptor-regulated response not mediated through cyclic AMP. Journal of Neurochemistry. 39: 976-81. PMID 6181195  0.96
1981 Chéramy A, Leviel V, Daudet F, Guibert B, Chesselet MF, Glowinski J. Involvement of the thalamus in the reciprocal regulation of the two nigrostriatal dopaminergic pathways. Neuroscience. 6: 2657-68. PMID 7322356  0.84
1981 Chesselet MF, Chéramy A, Reisine TD, Glowinski J. Morphine and delta-opiate agonists locally stimulate in vivo dopamine release in cat caudate nucleus. Nature. 291: 320-2. PMID 7231551  0.96
1981 Leviel V, Chesselet MF, Glowinski J, Chéramy A. Involvement of the thalamus in the asymmetric effects of unilateral sensory stimuli on the two nigrostriatal dopaminergic pathways in the cat. Brain Research. 223: 257-72. PMID 6169401 DOI: 10.1016/0006-8993(81)91140-9  0.96
1981 Chesselet MF, Lubetzki C, Reisine T. Local stimulatory effects of opiates on the in vivo release of dopamine in the cat caudate nucleus Neuroscience Letters. 24: S478.  0.96
Show low-probability matches.